David A. Cooper
National Centre in HIV Epidemiology and Clinical Research
University of New South Wales
Sydney
Australia
Name/email consistency: high
- The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy. Cooper, D.A., Cordery, D.V., Reiss, P., Henry, K., Nelson, M., O'Hearn, M., Reynes, J., Arastéh, K., Chung, J., Rowell, L., Guimaraes, D., Bertasso, A. HIV Med. (2011)
- Life and death in the cART era. Cooper, D.A. Lancet (2008)
- Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development. Cooper, D.A., Lange, J.M. Lancet. Infect. Dis (2004)